Literature DB >> 30460540

Next-Generation Sequencing Identifies Novel RTK VUSs in Breast Cancer with an Emphasis on ROS1, ERBB4, ALK and NTRK3.

Matthew K Stein1,2, Lindsay K Morris3, Mike G Martin4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30460540     DOI: 10.1007/s12253-018-0550-1

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


× No keyword cloud information.
  5 in total

1.  Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers.

Authors:  Laura D Wood; Eric S Calhoun; Natalie Silliman; Janine Ptak; Steve Szabo; Steve M Powell; Gregory J Riggins; Tian-Li Wang; Hai Yan; Adi Gazdar; Scott E Kern; Len Pennacchio; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Hum Mutat       Date:  2006-10       Impact factor: 4.878

2.  A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer.

Authors:  Philip Stephens; Sarah Edkins; Helen Davies; Chris Greenman; Charles Cox; Chris Hunter; Graham Bignell; Jon Teague; Raffaella Smith; Claire Stevens; Sarah O'Meara; Adrian Parker; Patrick Tarpey; Tim Avis; Andy Barthorpe; Lisa Brackenbury; Gemma Buck; Adam Butler; Jody Clements; Jennifer Cole; Ed Dicks; Ken Edwards; Simon Forbes; Matthew Gorton; Kristian Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jonathon Hinton; David Jones; Vivienne Kosmidou; Ross Laman; Richard Lugg; Andrew Menzies; Janet Perry; Robert Petty; Keiran Raine; Rebecca Shepherd; Alexandra Small; Helen Solomon; Yvonne Stephens; Calli Tofts; Jennifer Varian; Anthony Webb; Sofie West; Sara Widaa; Andrew Yates; Francis Brasseur; Colin S Cooper; Adrienne M Flanagan; Anthony Green; Maggie Knowles; Suet Y Leung; Leendert H J Looijenga; Bruce Malkowicz; Marco A Pierotti; Bin Teh; Siu T Yuen; Andrew G Nicholson; Sunil Lakhani; Douglas F Easton; Barbara L Weber; Michael R Stratton; P Andrew Futreal; Richard Wooster
Journal:  Nat Genet       Date:  2005-05-22       Impact factor: 38.330

3.  Activating ERBB4 mutations in non-small cell lung cancer.

Authors:  K J Kurppa; K Denessiouk; M S Johnson; K Elenius
Journal:  Oncogene       Date:  2015-06-08       Impact factor: 9.867

4.  A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast Cancer.

Authors:  C Anthony Blau; Arturo B Ramirez; Sibel Blau; Colin C Pritchard; Michael O Dorschner; Stephen C Schmechel; Timothy J Martins; Elisabeth M Mahen; Kimberly A Burton; Vitalina M Komashko; Amie J Radenbaugh; Katy Dougherty; Anju Thomas; Christopher P Miller; James Annis; Jonathan R Fromm; Chaozhong Song; Elizabeth Chang; Kellie Howard; Sharon Austin; Rodney A Schmidt; Michael L Linenberger; Pamela S Becker; Francis M Senecal; Brigham H Mecham; Su-In Lee; Anup Madan; Roy Ronen; Janusz Dutkowski; Shelly Heimfeld; Brent L Wood; Jackie L Stilwell; Eric P Kaldjian; David Haussler; Jingchun Zhu
Journal:  J Natl Compr Canc Netw       Date:  2016-01       Impact factor: 11.908

Review 5.  ALK: a tyrosine kinase target for cancer therapy.

Authors:  Vijaykumar R Holla; Yasir Y Elamin; Ann Marie Bailey; Amber M Johnson; Beate C Litzenburger; Yekaterina B Khotskaya; Nora S Sanchez; Jia Zeng; Md Abu Shufean; Kenna R Shaw; John Mendelsohn; Gordon B Mills; Funda Meric-Bernstam; George R Simon
Journal:  Cold Spring Harb Mol Case Stud       Date:  2017-01
  5 in total
  1 in total

1.  Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer.

Authors:  Eliezer M Van Allen; Geoffrey I Shapiro; Sara M Tolaney; Tanya E Keenan; Tianyu Li; Tuulia Vallius; Jennifer L Guerriero; Nabihah Tayob; Bose Kochupurakkal; Janae Davis; Ricardo Pastorello; Rie K Tahara; Leilani Anderson; Jake Conway; Meng X He; Erin Shannon; Robert E Godin; Peter K Sorger; Alan D'Andrea; Beth Overmoyer; Eric P Winer; Elizabeth A Mittendorf
Journal:  Clin Cancer Res       Date:  2020-11-30       Impact factor: 13.801

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.